Ana Borrego-Sánchez

Dr. Ana Borrego-Sánchez


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Applied Clay Science
Verified
Journal Article
Closed access
CVCésar Viseras
César Viseras
PCP. Cerezo
P. Cerezo
RSR. Sanchez
R. Sanchez
ISInmaculada Salcedo-Bellido
Inmaculada Salcedo-Bellido
CAC. Aguzzi
C. Aguzzi

1 April 2007 in Applied Clay Science
Verified
Journal Article
Closed access
CVCésar Viseras
César Viseras
CAC Aguzzi
C Aguzzi
PCP Cerezo
P Cerezo
Alberto Lopez GalindoAlberto Lopez Galindo
Alberto Lopez Galindo

1 January 2017 in Applied Clay Science
Verified
Journal Article
Closed access
NBN. Belhouchat
N. Belhouchat
HZH. Zaghouane-Boudiaf
H. Zaghouane-Boudiaf
CVCésar Viseras
César Viseras

1 November 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MAMahmoud E. Awad
Mahmoud E. Awad
Alberto Lopez GalindoAlberto Lopez Galindo
Alberto Lopez Galindo
MSMassimo Setti
Massimo Setti
MEMahmoud M. El-Rahmany
Mahmoud M. El-Rahmany
CVCésar Viseras
César Viseras

1 July 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
Giuseppina SandriGiuseppina Sandri
Giuseppina Sandri
CACarola Aguzzi
Carola Aguzzi
Silvia RossiSilvia Rossi
Silvia Rossi
Maria Cristina BonferoniMaria Cristina Bonferoni
Maria Cristina Bonferoni
GBGiovanna Bruni
Giovanna Bruni
FFFranca Ferrari
Franca Ferrari

1 September 2008 in Materials Science and Technology
Verified
Journal Article
Closed access
CVCésar Viseras
César Viseras
CAC. Aguzzi
C. Aguzzi
PCP. Cerezo
P. Cerezo
MBM. C. Bedmar
M. C. Bedmar
Polymer–clay nanocomposites have attracted great attention worldwide from both academic and industrial points of view. This review aims at reporting on very recent developments in types of polymer–clay nanocomposites, their constituents, synthetic routes, properties and their uses as carriers for drug delivery. This new family of composite materials frequently exhibits remarkable improvements of material properties when compared with the matrix polymers alone or conventional micro- and macrocomposites. Pharmaceutically, interesting improvements include increased mechanical and rheological properties, reduced drug permeability and water uptake and controlled release characteristics. On the basis of these properties, polymer–clay nanocomposites are extending their applicability to the design of new drug release dosage forms with highly specific technological and biopharmaceutical properties, such as swelling, film forming, bioadhesion, and cell uptake. Overall, there is an essential requirement directed towards a more comprehensive understanding of the supramolecular structure, drug loading and release mechanisms of these hybrid materials.